Jim Cramer on Thermo Fisher: “Maybe This Stock Can Finally Get its Groove Back”

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the stocks Jim Cramer put under the spotlight recently. Cramer discussed the company’s latest earnings, as he commented:

“So what do we make of these numbers from Thermo Fisher Scientific, a company I’ve liked for so long? It’s a big life sciences company, reported better than expected quarter this morning… [It] delivered a nice top and bottom line beat with accelerating organic revenue growth. So, maybe this stock can finally get its groove back after mostly trading sideways for the past few years. All for legitimate reasons.”

A person with stock market data on a laptop. Photo by Anna Nekrashevich on Pexels

Thermo Fisher Scientific Inc. (NYSE:TMO) supplies laboratory products, analytical instruments, diagnostics, and biopharma services that support scientific research, healthcare, and industrial applications. On October 1, a caller asked about the stock, and Cramer responded:

“Oh yeah… they really got hurt by COVID. I gotta tell you, as good as Marc Casper is at Thermo Fisher, I’m still saying that Danaher’s better. They’ve both been in the same junk heap, and they shouldn’t have been. Danaher, I think, has got more going for it right now than Thermo Fisher. I would do DHR. That’s a club name.”

While we acknowledge the risk and potential of TMO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than TMO and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.